709 results found.
                    
FDA Approves Medtronic's INFUSE Bone Graft for New Spine Indications
FDA has approved additional spine surgery indications for Medtronic's Infuse® Bone Graft, s...
Medtronic Reports FY2Q16 Revenue
Medtronic posted FY2Q16 (ended 10/30/15) spinal revenue of
Investors Shy From Start-Up Risk, Continue to Back Growth-Stage Companies
By Carolyn LaWell Investors continue to back growth-stage device companies and those at the intersection of medical and information technology, as opposed to start-ups—a trend that is expected to endure in 2016. The investment community’s oppositio...
Funding Sources: Four Company Snapshots
By Hannah Corcoran Securing funding is a critical step for companies as they jump the hurdles to market entry. The most common way that early-stage companies seek funding is to issue equity to investors (usually preferred stock, sometimes common stock), a...
NASS Revises Coverage Recommendation for Cervical Artificial Disc Replacement
The North American Spine Society (NASS) has revised its formal coverage recommendation for Cervical Artificial Disc Re...
Study Refutes Increased Cancer Risk after rhBMP for Spinal Fusion
Studies investigating use of recombinant human bone morphogenetic protein (rhBMP) in spinal fusion found high rates o...
Greatbatch Announces 3Q15 Revenue, Comments on Acquisition
Greatbatch posted 3Q15 orthopaedic revenue of US $27.5MM, -15% from 3Q14 (-7% in organic constant currency). 
Greatbatch Completes Acquisition, to Rebrand as Integer
Greatbatch, a supplier of implants, instruments, cases and trays to orthopaedic OEMs, completed its acquisition of
NASS 2015: Interbody Fusion, SI Joint, Robotics Take Spotlight
By Carolyn LaWell While the spine market continues to grow in the low-single-digits, small- to mid-sized pure-play companies remain confident that their data-backed products will keep taking market share from larger, diversified players. That sentiment carried...
Spine Spotlight: A Look Back, a Look Ahead
News from NASS reaffirmed industry trends that we cited in this year’s edition of THE O...
Study: Prestige LP Cervical Disc Patients Maintained Improved Clinical Outcomes, Patient Satisfaction vs. Fusion at 7 Years
Seven-year study data indicate that Medtronic's Prestige LP™ cervical disc maintained improved clinical ...
Biologica Technologies Introduces ProteiOS Growth Factor
Biologica Technologies is debuting ProteiOS™, growth factor derived from minimally manipulated allogenei...
NASS Preview: Products and Companies to Watch
By Julie Vetalice Spine-centric product news and personnel announcements are ramping up as we near the mid-October annual meeting of NASS, the North American Spine Society. Recent analyst notes suggest that pure-play companies continue to outperform larger diversifi...
Orthopaedic Investments Not Halted by China’s Challenged Economy
By Carolyn LaWell While China’s stock market volatility has disrupted global markets and fueled fears of a sliding economy, current events haven’t appreciably affected the country’s healthcare market and shouldn’t deter medical device i...
BARE BONES® - September 3, 2015
Medtronic posted FY1Q16 (ended 7/31/15) spinal revenue of US $763MM, +7% from FY1Q15. (Core Spine WW flat, U.S. declined in mid-single digits; Interventional Spine WW declined in mid-single digits, U.S. declined high-single di...
The Consolidation Climate: What Trends Prevail?
By Carolyn LaWell Through the first half of 2015, the number of merger and acquisition transactions closed has kept pace with the amount of deals that took place during the same time periods in ...
International and Domestic Manufacturers Compete to Serve Growing Asian Population
By Ames Gross, Pacific Bridge Medical   Why Orthopaedics Will Grow in Asia Orthopaedics remains an attractive and growing market, especially in Asia. Multiple factors contribute to the growth of the orthopaedic market in this region. ...
BARE BONES® - July 8, 2015
Medtronic commenced global launch of the CD HORIZON® SOLERA® VOYAGER™ Spinal System, designed to offer multiple minimally invasive rod insertion options and a 3D-navigated surg...
Spine and Joint Lead Investor Interest in 1H15
Funds raised in the first half of 2015 show continued interest in support of the spine and joint reconstruction segments: of the $135 million we’ve reported thus far, both claim over 28 percent of the whole. Orthobiologic companies, whose products have application across different segmen...
BARE BONES® - June 2, 2015
Medtronic posted 4QFY15 and fiscal year 2015 (ended 4/24/15) spinal revenue of US $743MM, -2% and $2,971MM, -1% year over year, respectively. Growth reflects constant currency. (
BARE BONES® - May 19, 2015
For FY4Q15 (ended 4/24/15), Medtronic reported preliminary spine revenue of US $743MM, -2% vs. 4Q14. (Medtronic plc...
BARE BONES® - May 4, 2015
Medtronic received FDA clearance to market the ZEVO™ Anterior Cervical Plate, indicated for treatment of cervical degenerative disc disease, trauma, tumors, deformity, pseudoarthrosis and failed ...
BARE BONES® - May 4, 2015
Medtronic launched the DIVERGENCE™ Stand Alone Interbody Cage, indicated for anterior cervical interbody fusion in skeletally mature patients with cervical disc disease at 1 level from
BARE BONES® - April 17, 2015
One-year results from a pilot feasibility study comparing Vexim's SpineJack® to Medtronic's balloon in the treatment of vertebral compression fractures in osteoporosi...
Navigation and Preoperative Planning Solutions Drive New Generation of Robotics
In writing this year’s installment of THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT®, we were drawn to the amount of strategic activity that surrounded computer assisted surgery systems, includ...
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group